3H-imipramine binding in blood platelets of schizophrenic patients.
3H-Imipramine binding was studied in the blood platelets of 51 unmedicated chronic schizophrenic patients. Univariate analyses of log-transformed data revealed that Bmax was significantly lower in schizophrenic patients than normal volunteers; Kd was nonsignificantly higher in the schizophrenics. A multivariate analysis of variance indicated the Kd and Bmax both differ significantly between normal controls and schizophrenic patients in the direction of increased Kd and decreased Bmax in the schizophrenics. These results indicate that decreased platelet imipramine binding is not specific for major depression.
D000328:Adult; D001792:Blood Platelets / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007099:Imipramine / Q000097:blood*; D007700:Kinetics; D046911:Macromolecular Substances; D008297:Male; D012559:Schizophrenia / Q000097:blood*; D012701:Serotonin / Q000378:metabolism
D046911:Macromolecular Substances; D012701:Serotonin; D007099:Imipramine